The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Anti-Neoplastic Pharmaceutical Agents Market Research Report 2025
Synopsis
Anti-neoplastic are the drugs that prevent growth of any abnormal tissue leading to cancer. The drugs pass into the human body and destroy cancerous cells. These drugs are also used in conjunction with surgery, radiotherapy and immunotherapy for solid tumors. The anti-neoplastic pharmaceutical agents are also known as cytotoxic agents .The changing lifestyle across the globe is increasing the chances of cancer which leads to high demand for the anti-neoplastic pharmaceutical agents from pharmaceutical companies.
The global Anti-Neoplastic Pharmaceutical Agents market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Anti-Neoplastic Pharmaceutical Agents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Neoplastic Pharmaceutical Agents.
Report Scope
The Anti-Neoplastic Pharmaceutical Agents market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anti-Neoplastic Pharmaceutical Agents market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-Neoplastic Pharmaceutical Agents companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithKline plc.
F. Hoffmann-La Roche Ltd
Eli Lilly and Company
Bristol-Myers Squibb Company
Becton, Dickinson and Company
Pfizer Inc.
Novartis AG
AstraZeneca
Gilead
Segment by Type
Hormones and Antagonists
Microorganism Products
Plant Products
Antitumor Antibiotics
Alkylating Agents
Antimetabolites
Natural Products
Segment by Application
Lung Cancer
Bladder Cancer
Breast Cancer
Cervical Cancer
Leukemia
Gynecological Cancer
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Anti-Neoplastic Pharmaceutical Agents companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Anti-neoplastic are the drugs that prevent growth of any abnormal tissue leading to cancer. The drugs pass into the human body and destroy cancerous cells. These drugs are also used in conjunction with surgery, radiotherapy and immunotherapy for solid tumors. The anti-neoplastic pharmaceutical agents are also known as cytotoxic agents .The changing lifestyle across the globe is increasing the chances of cancer which leads to high demand for the anti-neoplastic pharmaceutical agents from pharmaceutical companies.
The global Anti-Neoplastic Pharmaceutical Agents market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Anti-Neoplastic Pharmaceutical Agents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Neoplastic Pharmaceutical Agents.
Report Scope
The Anti-Neoplastic Pharmaceutical Agents market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anti-Neoplastic Pharmaceutical Agents market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-Neoplastic Pharmaceutical Agents companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithKline plc.
F. Hoffmann-La Roche Ltd
Eli Lilly and Company
Bristol-Myers Squibb Company
Becton, Dickinson and Company
Pfizer Inc.
Novartis AG
AstraZeneca
Gilead
Segment by Type
Hormones and Antagonists
Microorganism Products
Plant Products
Antitumor Antibiotics
Alkylating Agents
Antimetabolites
Natural Products
Segment by Application
Lung Cancer
Bladder Cancer
Breast Cancer
Cervical Cancer
Leukemia
Gynecological Cancer
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Anti-Neoplastic Pharmaceutical Agents companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-Neoplastic Pharmaceutical Agents Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Hormones and Antagonists
1.2.3 Microorganism Products
1.2.4 Plant Products
1.2.5 Antitumor Antibiotics
1.2.6 Alkylating Agents
1.2.7 Antimetabolites
1.2.8 Natural Products
1.3 Market by Application
1.3.1 Global Anti-Neoplastic Pharmaceutical Agents Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Lung Cancer
1.3.3 Bladder Cancer
1.3.4 Breast Cancer
1.3.5 Cervical Cancer
1.3.6 Leukemia
1.3.7 Gynecological Cancer
1.3.8 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anti-Neoplastic Pharmaceutical Agents Market Perspective (2019-2030)
2.2 Anti-Neoplastic Pharmaceutical Agents Growth Trends by Region
2.2.1 Global Anti-Neoplastic Pharmaceutical Agents Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Anti-Neoplastic Pharmaceutical Agents Historic Market Size by Region (2019-2024)
2.2.3 Anti-Neoplastic Pharmaceutical Agents Forecasted Market Size by Region (2025-2030)
2.3 Anti-Neoplastic Pharmaceutical Agents Market Dynamics
2.3.1 Anti-Neoplastic Pharmaceutical Agents Industry Trends
2.3.2 Anti-Neoplastic Pharmaceutical Agents Market Drivers
2.3.3 Anti-Neoplastic Pharmaceutical Agents Market Challenges
2.3.4 Anti-Neoplastic Pharmaceutical Agents Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anti-Neoplastic Pharmaceutical Agents Players by Revenue
3.1.1 Global Top Anti-Neoplastic Pharmaceutical Agents Players by Revenue (2019-2024)
3.1.2 Global Anti-Neoplastic Pharmaceutical Agents Revenue Market Share by Players (2019-2024)
3.2 Global Anti-Neoplastic Pharmaceutical Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Anti-Neoplastic Pharmaceutical Agents Revenue
3.4 Global Anti-Neoplastic Pharmaceutical Agents Market Concentration Ratio
3.4.1 Global Anti-Neoplastic Pharmaceutical Agents Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-Neoplastic Pharmaceutical Agents Revenue in 2023
3.5 Anti-Neoplastic Pharmaceutical Agents Key Players Head office and Area Served
3.6 Key Players Anti-Neoplastic Pharmaceutical Agents Product Solution and Service
3.7 Date of Enter into Anti-Neoplastic Pharmaceutical Agents Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-Neoplastic Pharmaceutical Agents Breakdown Data by Type
4.1 Global Anti-Neoplastic Pharmaceutical Agents Historic Market Size by Type (2019-2024)
4.2 Global Anti-Neoplastic Pharmaceutical Agents Forecasted Market Size by Type (2025-2030)
5 Anti-Neoplastic Pharmaceutical Agents Breakdown Data by Application
5.1 Global Anti-Neoplastic Pharmaceutical Agents Historic Market Size by Application (2019-2024)
5.2 Global Anti-Neoplastic Pharmaceutical Agents Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Anti-Neoplastic Pharmaceutical Agents Market Size (2019-2030)
6.2 North America Anti-Neoplastic Pharmaceutical Agents Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Anti-Neoplastic Pharmaceutical Agents Market Size by Country (2019-2024)
6.4 North America Anti-Neoplastic Pharmaceutical Agents Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Anti-Neoplastic Pharmaceutical Agents Market Size (2019-2030)
7.2 Europe Anti-Neoplastic Pharmaceutical Agents Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Country (2019-2024)
7.4 Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Anti-Neoplastic Pharmaceutical Agents Market Size (2019-2030)
8.2 Asia-Pacific Anti-Neoplastic Pharmaceutical Agents Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Anti-Neoplastic Pharmaceutical Agents Market Size by Region (2019-2024)
8.4 Asia-Pacific Anti-Neoplastic Pharmaceutical Agents Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Anti-Neoplastic Pharmaceutical Agents Market Size (2019-2030)
9.2 Latin America Anti-Neoplastic Pharmaceutical Agents Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Anti-Neoplastic Pharmaceutical Agents Market Size by Country (2019-2024)
9.4 Latin America Anti-Neoplastic Pharmaceutical Agents Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anti-Neoplastic Pharmaceutical Agents Market Size (2019-2030)
10.2 Middle East & Africa Anti-Neoplastic Pharmaceutical Agents Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Anti-Neoplastic Pharmaceutical Agents Market Size by Country (2019-2024)
10.4 Middle East & Africa Anti-Neoplastic Pharmaceutical Agents Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline plc.
11.1.1 GlaxoSmithKline plc. Company Detail
11.1.2 GlaxoSmithKline plc. Business Overview
11.1.3 GlaxoSmithKline plc. Anti-Neoplastic Pharmaceutical Agents Introduction
11.1.4 GlaxoSmithKline plc. Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2019-2024)
11.1.5 GlaxoSmithKline plc. Recent Development
11.2 F. Hoffmann-La Roche Ltd
11.2.1 F. Hoffmann-La Roche Ltd Company Detail
11.2.2 F. Hoffmann-La Roche Ltd Business Overview
11.2.3 F. Hoffmann-La Roche Ltd Anti-Neoplastic Pharmaceutical Agents Introduction
11.2.4 F. Hoffmann-La Roche Ltd Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2019-2024)
11.2.5 F. Hoffmann-La Roche Ltd Recent Development
11.3 Eli Lilly and Company
11.3.1 Eli Lilly and Company Company Detail
11.3.2 Eli Lilly and Company Business Overview
11.3.3 Eli Lilly and Company Anti-Neoplastic Pharmaceutical Agents Introduction
11.3.4 Eli Lilly and Company Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2019-2024)
11.3.5 Eli Lilly and Company Recent Development
11.4 Bristol-Myers Squibb Company
11.4.1 Bristol-Myers Squibb Company Company Detail
11.4.2 Bristol-Myers Squibb Company Business Overview
11.4.3 Bristol-Myers Squibb Company Anti-Neoplastic Pharmaceutical Agents Introduction
11.4.4 Bristol-Myers Squibb Company Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2019-2024)
11.4.5 Bristol-Myers Squibb Company Recent Development
11.5 Becton, Dickinson and Company
11.5.1 Becton, Dickinson and Company Company Detail
11.5.2 Becton, Dickinson and Company Business Overview
11.5.3 Becton, Dickinson and Company Anti-Neoplastic Pharmaceutical Agents Introduction
11.5.4 Becton, Dickinson and Company Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2019-2024)
11.5.5 Becton, Dickinson and Company Recent Development
11.6 Pfizer Inc.
11.6.1 Pfizer Inc. Company Detail
11.6.2 Pfizer Inc. Business Overview
11.6.3 Pfizer Inc. Anti-Neoplastic Pharmaceutical Agents Introduction
11.6.4 Pfizer Inc. Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2019-2024)
11.6.5 Pfizer Inc. Recent Development
11.7 Novartis AG
11.7.1 Novartis AG Company Detail
11.7.2 Novartis AG Business Overview
11.7.3 Novartis AG Anti-Neoplastic Pharmaceutical Agents Introduction
11.7.4 Novartis AG Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2019-2024)
11.7.5 Novartis AG Recent Development
11.8 AstraZeneca
11.8.1 AstraZeneca Company Detail
11.8.2 AstraZeneca Business Overview
11.8.3 AstraZeneca Anti-Neoplastic Pharmaceutical Agents Introduction
11.8.4 AstraZeneca Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2019-2024)
11.8.5 AstraZeneca Recent Development
11.9 Gilead
11.9.1 Gilead Company Detail
11.9.2 Gilead Business Overview
11.9.3 Gilead Anti-Neoplastic Pharmaceutical Agents Introduction
11.9.4 Gilead Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2019-2024)
11.9.5 Gilead Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
